Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
LncRNA LYPLAL1-DT screening from type 2 diabetes with macrovascular complication contributes protective effects on human umbilical vein endothelial cells via regulating the miR-204-5p/SIRT1 axis.
Sex differences in type 2 diabetes.
Kautzky-Willer A, Leutner M, Harreiter J.
Diabetologia. 2023 Jun;66(6):986-1002. doi: 10.1007/s00125-023-05891-x. Epub 2023 Mar 10.
Macrovascular Complications of Type 2 Diabetes Mellitus.
Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T.
Curr Vasc Pharmacol. 2020;18(2):110-116. doi: 10.2174/1570161117666190405165151.
Type-2 diabetes mellitus and cardiovascular disease.
Henning RJ.
Future Cardiol. 2018 Nov;14(6):491-509. doi: 10.2217/fca-2018-0045. Epub 2018 Nov 9.
A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.
Izzo A, Massimino E, Riccardi G, Della Pepa G.
Nutrients. 2021 Jan 9;13(1):183. doi: 10.3390/nu13010183.
Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus.
Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW.
Rev Diabet Stud. 2022 Sep 28;18(3):157-165. doi: 10.1900/RDS.2022.18.157.
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
Patel A; ADVANCE Collaborative Group; MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.
Lancet. 2007 Sep 8;370(9590):829-40. doi: 10.1016/S0140-6736(07)61303-8.
Overview of oxidative stress and inflammation in diabetes.
Weinberg Sibony R, Segev O, Dor S, Raz I.
J Diabetes. 2024 Oct;16(10):e70014. doi: 10.1111/1753-0407.70014.
Accelerometer-measured physical activity, sedentary behavior, and incidence of macrovascular and microvascular events in individuals with type 2 diabetes mellitus and prediabetes.
Liang YY, He Y, Huang P, Feng H, Li H, Ai S, Du J, Xue H, Liu Y, Zhang J, Qi L, Zhang J.
J Sport Health Sci. 2025 Dec;14:100973. doi: 10.1016/j.jshs.2024.100973. Epub 2024 Aug 29.
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
Yapanis M, James S, Craig ME, O'Neal D, Ekinci EI.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034.
The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms.
Massimino E, Izzo A, Riccardi G, Della Pepa G.
Cells. 2021 Aug 1;10(8):1958. doi: 10.3390/cells10081958.
